Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 775
Improving Genetic Counseling for BRCA+ Mothers
for
Breast Cancer
Location: Washington DC
Sponsor: Georgetown University
Sex: Female
Age: 18+
Code: NCT04258280
Recruiting
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
for
Advanced Colorectal Carcinoma,
Location: Washington D.C. DC, Winchester VA, Elkton MD, Newark DE,
Sponsor: University of Rochester
Sex: All
Age: 18+
Code: NCT06073431
Recruiting
NCI SBIR Contract for Patient Navigation Tool Prototype Development
Get alerts for new trials in your area by subscribing now
Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation
for
Liver Transplant
Location: Washington D.C. DC, Pittsburgh PA, New York NY,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 3 - 13
Code: NCT07549503
Phase 2, Recruiting
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Washington D.C. DC, Newark DE, Richmond VA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT03739814
Phase 2, Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Washington D.C. DC, Richmond VA, Norfolk VA,
Sponsor: Lyell Immunopharma, Inc.
Sex: All
Age: 18+
Code: NCT07188558
Phase 3, Recruiting
Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty
for
Primary Total Hip Arthroplasty
Location: Washington D.C. DC
Sponsor: Medstar Health Research Institute
Sex: All
Age: 18 - 70+
Code: NCT07337642
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Washington D.C. DC, Bethesda MD, Frederick MD,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07225504
Phase 3, Recruiting
RESvEraTrol in Parkinson's Disease (RESET)
for
Parkinson's Disease
Location: Washington D.C. DC
Sponsor: Georgetown University
Sex: All
Age: 55 - 70+
Code: NCT07592767
Phase 2, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Washington D.C. DC, Bethesda MD, Clinton MD, Olney MD,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase 3, Recruiting
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
for
Castration-Sensitive Prostate Carcinoma,
Location: Washington D.C. DC, Fredericksburg VA, Tappahannock VA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: Male
Age: 18+
Code: NCT06931340
Phase 3, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Washington D.C. DC, Newark DE, Philadelphia PA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase 3, Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia
for
Immune Thrombocytopenia (ITP)
Location: Washington D.C. DC, Rochester MN, New Orleans LA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06721013
Phase 1, Phase 2, Recruiting
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
for
Pancreatic Neoplasm
Location: Washington D.C. DC, Alexandria VA, Fairfax VA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 50 - 70+
Code: NCT04239573
Recruiting
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Washington D.C. DC, Fairfax VA, New York NY, Toronto,
Location: Washington D.C. DC, Camden NJ, New Haven CT,
Sponsor: Cook Research Incorporated
Sex: All
Age: 18+
Code: NCT07144150
Recruiting
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,